Autonomy Isn’t Binary: How Agentic AI Fits into the Pharma Landscape

In September 2025, PharmTech® published the first of what became a three-part series on setting expectations for agentic AI in the pharmaceutical industry, authored by Jason Bryant, senior vice-president of Product Management—AI at ArisGlobal.

As 2025 turns to 2026, PharmTech® has interviewed Bryant for a video supplement to these articles, which will again be published in three parts. In this first installment, Bryant makes the distinction between autonomy and accountability in AI agents, and how these characteristics must work in tandem. Bryant emphasizes that when it comes to agentic AI’s deployment for pharma, “autonomy…